554 related articles for article (PubMed ID: 17574036)
1. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study.
Whitson BA; Leslie DB; Kellogg TA; Maddaus MA; Buchwald H; Billington CJ; Ikramuddin S
J Surg Res; 2007 Jul; 141(1):31-9. PubMed ID: 17574036
[TBL] [Abstract][Full Text] [Related]
2. Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study.
Whitson BA; Leslie DB; Kellogg TA; Maddaus MA; Buchwald H; Billington CJ; Ikramuddin S
J Surg Res; 2007 Oct; 142(2):295-300. PubMed ID: 17640666
[TBL] [Abstract][Full Text] [Related]
3. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
[TBL] [Abstract][Full Text] [Related]
4. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass.
Stoeckli R; Chanda R; Langer I; Keller U
Obes Res; 2004 Feb; 12(2):346-50. PubMed ID: 14981228
[TBL] [Abstract][Full Text] [Related]
5. Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer.
Couce ME; Cottam D; Esplen J; Schauer P; Burguera B
Obes Surg; 2006 Jul; 16(7):870-8. PubMed ID: 16839485
[TBL] [Abstract][Full Text] [Related]
6. Pre- and post-prandial plasma ghrelin levels do not correlate with satiety or failure to achieve a successful outcome after Roux-en-Y gastric bypass.
Christou NV; Look D; McLean AP
Obes Surg; 2005 Aug; 15(7):1017-23. PubMed ID: 16105400
[TBL] [Abstract][Full Text] [Related]
7. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
Gumbs AA; Modlin IM; Ballantyne GH
Obes Surg; 2005 Apr; 15(4):462-73. PubMed ID: 15946423
[TBL] [Abstract][Full Text] [Related]
8. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.
Vendrell J; Broch M; Vilarrasa N; Molina A; Gómez JM; Gutiérrez C; Simón I; Soler J; Richart C
Obes Res; 2004 Jun; 12(6):962-71. PubMed ID: 15229336
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin: a gut-brain hormone: effect of gastric bypass surgery.
Geloneze B; Tambascia MA; Pilla VF; Geloneze SR; Repetto EM; Pareja JC
Obes Surg; 2003 Feb; 13(1):17-22. PubMed ID: 12630608
[TBL] [Abstract][Full Text] [Related]
10. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release.
Rodieux F; Giusti V; D'Alessio DA; Suter M; Tappy L
Obesity (Silver Spring); 2008 Feb; 16(2):298-305. PubMed ID: 18239636
[TBL] [Abstract][Full Text] [Related]
11. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
[TBL] [Abstract][Full Text] [Related]
12. Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia.
Frühbeck G; Rotellar F; Hernández-Lizoain JL; Gil MJ; Gómez-Ambrosi J; Salvador J; Cienfuegos JA
Obes Surg; 2004 Oct; 14(9):1208-15. PubMed ID: 15527636
[TBL] [Abstract][Full Text] [Related]
13. Peptide YY levels are elevated after gastric bypass surgery.
Chan JL; Mun EC; Stoyneva V; Mantzoros CS; Goldfine AB
Obesity (Silver Spring); 2006 Feb; 14(2):194-8. PubMed ID: 16571843
[TBL] [Abstract][Full Text] [Related]
14. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion.
Lugari R; Dei Cas A; Ugolotti D; Barilli AL; Camellini C; Ganzerla GC; Luciani A; Salerni B; Mittenperger F; Nodari S; Gnudi A; Zandomeneghi R
Horm Metab Res; 2004 Feb; 36(2):111-5. PubMed ID: 15002062
[TBL] [Abstract][Full Text] [Related]
16. Postprandial changes in gut regulatory peptides in gastric bypass patients.
Holdstock C; Zethelius B; Sundbom M; Karlsson FA; Edén Engström B
Int J Obes (Lond); 2008 Nov; 32(11):1640-6. PubMed ID: 18794895
[TBL] [Abstract][Full Text] [Related]
17. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.
Suzuki S; Ramos EJ; Goncalves CG; Chen C; Meguid MM
Surgery; 2005 Aug; 138(2):283-90. PubMed ID: 16153438
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: a prospective comparative study.
Stratis C; Alexandrides T; Vagenas K; Kalfarentzos F
Obes Surg; 2006 Jun; 16(6):752-8. PubMed ID: 16756737
[TBL] [Abstract][Full Text] [Related]
19. Meal suppression of circulating ghrelin is normalized in obese individuals following gastric bypass surgery.
Engström BE; Ohrvall M; Sundbom M; Lind L; Karlsson FA
Int J Obes (Lond); 2007 Mar; 31(3):476-80. PubMed ID: 16924271
[TBL] [Abstract][Full Text] [Related]
20. Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery.
Tritos NA; Mun E; Bertkau A; Grayson R; Maratos-Flier E; Goldfine A
Obes Res; 2003 Aug; 11(8):919-24. PubMed ID: 12917494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
